Sex: a major predictor of remission in early rheumatoid arthritis? - PubMed (original) (raw)

Sex: a major predictor of remission in early rheumatoid arthritis?

K Forslind et al. Ann Rheum Dis. 2007 Jan.

Abstract

Background: The treatment goal of early rheumatoid arthritis is remission. This study reports remission rates in clinical practice using a cohort of patients with early rheumatoid arthritis.

Methods: 698 patients with early rheumatoid arthritis were included. Mean age at inclusion was 58 years and mean disease duration was 6.4 months; 64% of the patients were women, 56% were positive for antibodies to cyclic citrullinated peptide and 60% were positive for rheumatoid factor. Remission was defined as a disease activity score <2.6, with or without ongoing treatment with drugs for rheumatoid arthritis.

Results: After 2 years, 261 of 689 patients were in remission (37.9%), and after 5 years, the remission rate was 38.5%. However, only 26.1% were in remission at both these time points. Multiple logistic regression analyses found sex to be a main predictor for remission. Thus, significantly fewer women were in remission after 2 years (32.1% v 48%, p = 0.001) after 5 years (30.8% v 52.4%, p = 0.001) and at both these time points (19.1% v 39.3%, p = 0.001). Although disease activity was not with certainty more pronounced in women at onset of disease, the disease course became markedly worse in women. The disparity in remission frequency between women and men could not be explained by differences in disease duration, age or treatment with disease modifying antirheumatic drugs or glucocorticoids.

Conclusions: Early remission of rheumatoid arthritis by 28-joint Disease Activity Score<2.6 was as frequent or more frequent in this study than in most previous reports. Importantly, women had more severe disease with a considerably lower remission rate than men, although the disease activity before treatment seemed similar.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

Cited by

References

    1. EULAR handbook of clinical assessments in rheumatoid arthritis The Netherlands: van Zuiden Communications BV 2000
    1. Prevoo M L, van Gestel A M, van' t Hof M A, van Rijswijk M H, van de Putte L B, van Riel P L. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the Disease Activity Score. Br J Rheumatol 1996351101–1105. - PubMed
    1. Pinals R S, Masi A T, Larsen R A, and the subcommittee for criteria of remission in rheumatoid arthritis of the American Rheumatism Association diagnostic and therapeutic criteria committee Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981241308–1315. - PubMed
    1. Svensson B, Schaufelberger C, Teleman A, Theander J. Remission and response to early treatment of RA assessed by the Disease Activity Score. Rheumatology 2000391031–1036. - PubMed
    1. Balsa A, Carmona L, Gonzales‐Alvaro I, Belmonte M A, Tena X, Sanmarti R for the EMECAR Study Group Value of Disease Activity Score 28 (DAS28) and DAS28‐3 compared to American College of Rheumatology‐defined remission in rheumatoid arthritis. J Rheumatol 20043140–46. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources